What companies are AARD's competitors?

Aardvark Therapeutics, Inc. Common Stock (AARD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does AARD compare to its peers?

The peer comparison table on this page shows Aardvark Therapeutics, Inc. Common Stock (AARD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does AARD operate in?

Aardvark Therapeutics, Inc. Common Stock (AARD) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

AARD

Aardvark Therapeutics, Inc. Common Stock

NASDAQ·Biotechnology · Healthcare

$6.81$0.44−6.07%

After hours·$6.81+0.00%

Market cap$149.03M·Market closed·Aug 26 8:00 PM UTC

Frequently Asked Questions About AARD

What companies are AARD's competitors?: Aardvark Therapeutics, Inc. Common Stock (AARD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does AARD compare to its peers?: The peer comparison table on this page shows Aardvark Therapeutics, Inc. Common Stock (AARD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does AARD operate in?: Aardvark Therapeutics, Inc. Common Stock (AARD) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

AARD

Aardvark Therapeutics, Inc. Common Stock

NASDAQ·Biotechnology · Healthcare

$6.81$0.44−6.07%

After hours·$6.81+0.00%

Market cap$149.03M·Market closed·Aug 26 8:00 PM UTC

Peers


AVTX	Avalo Therapeutics, Inc.	$20.55	$1.1B
ASMB	Assembly Biosciences, Inc.	$35.42	$701.9M
ZURA	Zura Bio Limited	$5.99	$569.0M
ENTA	Enanta Pharmaceuticals, Inc.	$14.15	$411.5M
FHTX	Foghorn Therapeutics Inc.	$6.69	$392.8M
EPRX	Eupraxia Pharmaceuticals Inc.	$7.43	$248.8M
PYXS	Pyxis Oncology, Inc.	$3.34	$211.6M
CRBU	Caribou Biosciences, Inc.	$1.76	$174.6M
TNYA	Tenaya Therapeutics, Inc.	$0.70	$151.1M
NAUT	Nautilus Biotechnolgy, Inc.	$0.88	$112.2M

Frequently Asked Questions About AARD

What companies are AARD's competitors?: Aardvark Therapeutics, Inc. Common Stock (AARD)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does AARD compare to its peers?: The peer comparison table on this page shows Aardvark Therapeutics, Inc. Common Stock (AARD) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does AARD operate in?: Aardvark Therapeutics, Inc. Common Stock (AARD) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.